Compile Data Set for Download or QSAR
maximum 50k data
Found 30 Enz. Inhib. hit(s) with all data for entry = 6588
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140260(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  11nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47039(US8906933, (R)-3-ethoxy-2-hydroxy-5-(6-(1-methyl-1...)
Affinity DataIC50:  13nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47037(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  16nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140262(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  18nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM46437(US8906933, 4-(3-ethoxy-4-hydroxy-5-nitrophenyl)-6-...)
Affinity DataIC50:  19nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47045(US8906933, (R)-2-hydroxy-4-(6-(1-methyl-1H-pyrazol...)
Affinity DataIC50:  23nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47036(US8906933, 4-(3-ethoxy-4-hydroxy-5-nitrophenyl)-6-...)
Affinity DataIC50:  24nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47039(US8906933, (R)-3-ethoxy-2-hydroxy-5-(6-(1-methyl-1...)
Affinity DataIC50:  27nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140264(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  28nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM46287(US8906933, 4-(3-ethoxy-4-hydroxy-5-nitrophenyl)-5,...)
Affinity DataIC50:  29nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47043(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  35nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47045(US8906933, (R)-2-hydroxy-4-(6-(1-methyl-1H-pyrazol...)
Affinity DataIC50:  39nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47042(US8906933, 4-(3-ethoxy-4-hydroxy-5-nitrophenyl)-6-...)
Affinity DataIC50:  40nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM46438(US8906933, 4-(3-ethoxy-4-hydroxy-5-nitrophenyl)-5-...)
Affinity DataIC50:  43nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM46727(US8906933, (S)-3-ethoxy-2-hydroxy-5-(2-oxo-6-(pyri...)
Affinity DataIC50:  67nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140261(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  110nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM46726(US8906933, 3-ethoxy-2-hydroxy-5-(2-oxo-6-(pyridin-...)
Affinity DataIC50:  150nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47039(US8906933, (R)-3-ethoxy-2-hydroxy-5-(6-(1-methyl-1...)
Affinity DataIC50:  580nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140265(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  700nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140263(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  1.40E+3nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140263(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  1.82E+3nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47038(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  1.90E+3nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM46739(US8906933, (R)-3-ethoxy-2-hydroxy-5-(2-oxo-6-(pyri...)
Affinity DataIC50:  3.17E+3nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47045(US8906933, (R)-2-hydroxy-4-(6-(1-methyl-1H-pyrazol...)
Affinity DataIC50:  4.25E+3nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140265(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  6.02E+3nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140260(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  1.90E+4nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140261(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  1.97E+4nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140262(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  2.20E+4nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAlcohol dehydrogenase class-3(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM47044(US8906933, (R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  3.10E+4nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuromedin-K receptor(Homo sapiens (Human))
N30 Pharmaceuticals

US Patent
LigandPNGBDBM140264(US8906933, (S)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl...)
Affinity DataIC50:  5.50E+4nMpH: 7.4 T: 2°CAssay Description:Receptor binding assays were performed using crude membranes prepared from CHO cells expressing human NK3 receptor. Osanetant (SR142801), a non-pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent